Understanding BiTE Immunotherapy: How Bispecific T-Cell Engagers Target Cancer

CancerCast by Weill Cornell Medicine

Bispecific T-cell engager, or BiTE, therapy is an immunotherapy approach that helps the body’s own immune system target cancer cells by bringing immune cells and cancer cells together. In this episode of CancerCast, Dr....View more